Understanding Wegovy Dose Equivalent to Mounjaro for Safe Switching
When considering a switch from Mounjaro to Wegovy, understanding the dose equivalent relationship is essential for maintaining therapeutic effectiveness. Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist, while Wegovy contains semaglutide, a selective GLP-1 receptor agonist. Due to different mechanisms of action, there isn't a direct 1:1 dose equivalent between these medications. Your prescriber will typically start Wegovy at the standard 0.25mg weekly dose regardless of your current Mounjaro dose, following the established dose escalation schedule.
The transition from Mounjaro to Wegovy dose equivalent requires careful clinical consideration of your current response, side effects, and weight management goals. Most patients switching from Mounjaro 2.5mg find Wegovy 1mg-1.7mg provides comparable appetite suppression effects. Those on higher Mounjaro doses (10mg-15mg) often achieve similar benefits with Wegovy's maintenance dose of 2.4mg. Your EverydayMeds prescriber will assess your individual circumstances to determine the most appropriate starting dose and escalation timeline.
Switch & Save: Wegovy Dose Equivalent Pricing Advantages
Switching from Mounjaro to Wegovy dose equivalent can offer significant monthly savings for weight management treatment. Wegovy starter doses begin at £79.99 for 0.25mg, progressing through £94.99 (0.5mg) and £99.99 (1mg) before reaching maintenance levels. Our Intro Trio bundle (0.25mg, 0.5mg, 1mg) provides 12 weeks of treatment for £299.99, covering your complete dose escalation period. New customers receive additional savings with code FIRST40 applied at checkout, while returning customers use DOSE25.
The potential monthly savings when finding your optimal Wegovy dose equivalent to Mounjaro can exceed £30-50 depending on your required maintenance dose. Our Consistency bundles offer 8-week supplies: Consistency 1mg (×2 pens) for £209.99 or Consistency 1.7mg (×2 pens) for £309.99. For patients requiring maximum dose, our Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99. These structured pricing options help you budget effectively while transitioning to your therapeutic Wegovy dose equivalent.
Clinical Evidence Supporting Wegovy Dose Equivalent Effectiveness
The STEP clinical trial programme demonstrates Wegovy's effectiveness across its dose range, helping inform appropriate dose equivalent decisions when switching from Mounjaro. In STEP 1, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 2 specifically studied patients with type 2 diabetes, achieving approximately 9.6% weight reduction, relevant for those switching from diabetes-related GLP-1 treatments.
The STEP 5 trial's two-year data showed sustained weight loss of approximately 15.2%, supporting long-term effectiveness when patients find their optimal Wegovy dose equivalent to previous treatments. These results help prescribers determine appropriate dose targets when transitioning patients from other GLP-1 medications. The SELECT cardiovascular outcomes trial recently demonstrated a 20% reduction in major cardiovascular events, adding important safety data for patients considering medication switches.
How Wegovy Works: Mechanism Behind Dose Equivalent Effects
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone to regulate appetite and food intake. Unlike Mounjaro's dual-hormone approach, Wegovy works specifically on GLP-1 receptors in the brain's appetite control centres, promoting feelings of fullness and reducing food cravings. The medication slows gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety between meals. Wegovy also influences reward pathways in the brain that govern food-seeking behaviour, potentially reducing preferences for high-calorie foods. This selective GLP-1 mechanism explains why dose equivalent effects between Wegovy and dual-agonist treatments like Mounjaro require individual clinical assessment rather than direct conversion ratios.
Streamlined Ordering Process for Wegovy Dose Equivalent Switching
EverydayMeds simplifies switching to your appropriate Wegovy dose equivalent with our comprehensive online service. Complete our 3-minute clinical assessment detailing your current medication, dose, and weight management history to help prescribers determine optimal starting doses. Standard prescriber review takes 3 working days, though express 24-hour review is available for faster medication transitions. Once approved, your prescription-only Wegovy is dispensed from our GPhC-registered pharmacy (#9012878) with next-day delivery via temperature-controlled cold-chain transport. Our clinical team coordinates your switch timing to ensure seamless transition between medications without treatment gaps.
Storage and Practical Considerations for Wegovy Dose Equivalent Management
Wegovy offers practical storage advantages over some alternative treatments, maintaining stability at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Store unused pens in the fridge at 2-8°C until ready for use, making travel and daily management more flexible. Each Wegovy pen uses Novo Nordisk's FlexTouch injection system with pre-attached needles, ensuring consistent dose delivery throughout your escalation schedule. The mandatory dose escalation from 0.25mg to 2.4mg over 16 weeks allows gradual adaptation to your therapeutic dose equivalent, minimising side effects during transition. Weekly injection timing can be adjusted ±3 days if needed, providing flexibility for your schedule while maintaining therapeutic effectiveness.
Strategic Switching: Why Patients Choose Wegovy Dose Equivalent Options
Many patients switch to Wegovy dose equivalent treatments for cost management, with potential monthly savings of £30-50+ making long-term weight management more sustainable. Side effect profiles differ between medications, and some patients find Wegovy's selective GLP-1 action causes fewer gastrointestinal effects than dual-hormone treatments. Availability considerations also influence switching decisions, as Wegovy's established UK supply chain through our GPhC-registered pharmacy ensures consistent medication access.
Storage convenience plays a practical role in medication switching, with Wegovy's 6-week room temperature stability offering travel advantages for frequent travellers or those with limited refrigeration access. Insurance and prescription coverage variations can make Wegovy dose equivalent options more accessible for certain patients. Our clinical team at EverydayMeds understands these switching motivations and tailors assessments accordingly, ensuring your transition supports both clinical outcomes and practical lifestyle needs.
Complete Your Switch to Wegovy: Dose Equivalent Support & Savings
Ready to explore Wegovy dose equivalent options? Our expert prescribers assess your current treatment response, medical history, and weight management goals to determine appropriate starting doses when switching from other GLP-1 medications. Use discount code FIRST40 (new customers) or DOSE25 (returning customers) at checkout for optimal pricing on your Wegovy prescription-only medicine. Both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which medication and dose equivalent best suits your individual needs. Start your clinical assessment today through our secure online platform, backed by our GPhC-registered pharmacy service (#9012878) and temperature-controlled delivery nationwide. Take the first step toward effective weight management with professional clinical support and transparent pricing at https://everydaymeds.co.uk/collections/weight-loss.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026